{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:26:09Z","timestamp":1778624769884,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201606230249"],"award-info":[{"award-number":["201606230249"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["STE 1022-2-4"],"award-info":[{"award-number":["STE 1022-2-4"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.dld.2019.02.015","type":"journal-article","created":{"date-parts":[[2019,3,31]],"date-time":"2019-03-31T06:47:01Z","timestamp":1554014821000},"page":"1300-1307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluating the best empirical antibiotic therapy in patients with acute-on-chronic liver failure and spontaneous bacterial peritonitis"],"prefix":"10.1016","volume":"51","author":[{"given":"Andreas","family":"Wieser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8816-0468","authenticated-orcid":false,"given":"Hanwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Liss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Markwardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Hornung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Suerbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Mayerle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander L.","family":"Gerbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian J.","family":"Steib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2019.02.015_bib0005","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"cute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.02.015_bib0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0036-1583195","article-title":"Predisposing factors in acute-on-chronic liver failure","volume":"36","author":"Trebicka","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2019.02.015_bib0015","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1586\/egh.11.47","article-title":"Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinicalmanifestations and potential therapeutic interventions","volume":"5","author":"Laleman","year":"2011","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.02.015_bib0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.dld.2011.08.029","article-title":"Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure","volume":"44","author":"Garg","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2019.02.015_bib0025","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.dld.2007.08.006","article-title":"Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure","volume":"39","author":"Di Campli","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2019.02.015_bib0030","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fern\u00e1ndez","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.02.015_bib0035","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.dld.2018.05.013","article-title":"Prevalence, predictors and impact of bacterial infection in acute on chronic liver failure patients","volume":"50","author":"Shalimar","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2019.02.015_bib0040","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.3748\/wjg.v22.i15.4049","article-title":"Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia","volume":"22","author":"Alexopoulou","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2019.02.015_bib0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/MCG.0000000000000704","article-title":"A real-world evaluation of repeat paracentesis-guided management of spontaneous bacterial peritonitis","volume":"51","author":"Goel","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2019.02.015_bib0050","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/liv.12985","article-title":"A randomized open label study of \u2018imipenem vs. cefepime\u2019 in spontaneous bacterial peritonitis","volume":"36","author":"Jindal","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2019.02.015_bib0055","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/jgh.13637","article-title":"Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis","volume":"32","author":"Kim","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.02.015_bib0060","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cgh.2010.11.038","article-title":"Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis","volume":"9","author":"Tandon","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.02.015_bib0065","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/ajg.2013.204","article-title":"The 22\/11 risk prediction model: a validated model for predicting 30-day mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"108","author":"Tandon","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.02.015_bib0070","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.02.015_bib0075","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.dld.2019.02.015_bib0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/hep.1840050319","article-title":"Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections","volume":"5","author":"Felisart","year":"1985","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.dld.2019.02.015_bib0085","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0016-5085(96)70069-0","article-title":"Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis","volume":"111","author":"Navasa","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.02.015_bib0090","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/hep.1840210312","article-title":"Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study","volume":"21","author":"Rimola","year":"1995","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.dld.2019.02.015_bib0095","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial","volume":"63","author":"Piano","year":"2016","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.dld.2019.02.015_bib0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijantimicag.2006.08.031","article-title":"Cefepime versus ceftazidime: considerations for empirical use in critically ill patients","volume":"29","author":"Roberts","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.dld.2019.02.015_bib0105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1179\/joc.2001.13.4.413","article-title":"An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin\/tazobactam, ceftazidime and ceftriaxone","volume":"13","author":"Varotto","year":"2001","journal-title":"J Chemother (Florence, Italy)"},{"issue":"Suppl. 2","key":"10.1016\/j.dld.2019.02.015_bib0110","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.cmi.2015.05.030","article-title":"Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus","volume":"21","author":"Lawson","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.dld.2019.02.015_bib0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1469-0691.2011.03703.x","article-title":"EUCAST expert rules in antimicrobial susceptibility testing","volume":"19","author":"Leclercq","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.dld.2019.02.015_bib0120","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1473-3099(11)70177-3","article-title":"Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis","volume":"11","author":"Tasina","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.dld.2019.02.015_bib0125","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/cid\/cis270","article-title":"Excess deaths associated with tigecycline after approval based on noninferiority trials","volume":"54","author":"Prasad","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.dld.2019.02.015_bib0130","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/jac\/dkr242","article-title":"Efficacy and safety of tigecycline: a systematic review and meta-analysis","volume":"66","author":"Yahav","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 4","key":"10.1016\/j.dld.2019.02.015_bib0135","first-page":"iv7","article-title":"Linezolid pharmacokinetics and pharmacodynamics in clinical treatment","volume":"66","author":"Dryden","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.dld.2019.02.015_bib0140","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1592\/phco.23.12.1322.32702","article-title":"Peritoneal dialysis fluid concentrations of linezolid in the treatment of vancomycin-resistant Enterococcus faecium peritonitis","volume":"23","author":"DePestel","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.dld.2019.02.015_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11596390-000000000-00000","article-title":"Vancomycin: a review of population pharmacokinetic analyses","volume":"51","author":"Marsot","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dld.2019.02.015_bib0150","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2215\/CJN.08510910","article-title":"Pharmacokinetics and pharmacodynamics of intravenous daptomycin during continuous ambulatory peritoneal dialysis","volume":"6","author":"Cardone","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.dld.2019.02.015_bib0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/cc13938","article-title":"Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy","volume":"18","author":"Ulldemolins","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.dld.2019.02.015_bib0160","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/sj.clpt.6100312","article-title":"Pharmacokinetics of meropenem determined by microdialysis in the peritoneal fluid of patients with severe peritonitis associated with septic shock","volume":"83","author":"Karjagin","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.02.015_bib0165","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1128\/AAC.47.9.2775-2780.2003","article-title":"Pharmacokinetics of linezolid in subjects with renal dysfunction","volume":"47","author":"Brier","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.dld.2019.02.015_bib0170","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/AAC.46.8.2723-2726.2002","article-title":"Hematologic effects of linezolid: summary of clinical experience","volume":"46","author":"Gerson","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.dld.2019.02.015_bib0175","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/01.CCM.0000164543.14619.00","article-title":"Daily cost of an intensive care unit day: the contribution of mechanical ventilation","volume":"33","author":"Dasta","year":"2005","journal-title":"Crit Care Med"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086581930101X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086581930101X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:34:10Z","timestamp":1778621650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086581930101X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S159086581930101X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2019.02.015","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the best empirical antibiotic therapy in patients with acute-on-chronic liver failure and spontaneous bacterial peritonitis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2019.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}